Tocainide associated agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced*; D006801:Humans; D008012:Lidocaine / Q000009:adverse effects / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D013610:Tachycardia / Q000188:drug therapy; D016677:Tocainide
D016677:Tocainide; D008012:Lidocaine